Adherence to treatment on a daily-dose regimen for TB

被引:0
|
作者
Rajavardhana, T. [1 ,2 ]
Koushik, M. R. [3 ]
Jayakumar, C. [4 ]
Ramalingam, P. [5 ]
Geethavani, M. [2 ]
Kumar, M. Ashok [6 ]
Rajanandh, M. G. [7 ]
机构
[1] Sri Ramachandra Inst Higher Educ & Res, Sri Ramachandra Fac Pharm, Dept Pharm Practice, Chennai, India
[2] Balaji Coll Pharm, Dept Pharm Practice, Ananthapuramu, India
[3] Sri Ramachandra Inst Higher Educ & Res, Sri Ramachandra Med Coll & Res Inst, Dept Resp Med, Chennai, India
[4] JSS Acad Higher Educ & Res, JSS Coll Pharm, Dept Pharm Practice, Udhagamandalam, India
[5] Natl Inst Pharmaceut Educ & Res, Dept Pharmaceut Anal, Export Promot Ind Pk, Hajipur, India
[6] Anantapur Med Coll & Govt Gen Hosp, Dept Pulmonol, Ananthapuramu, India
[7] SRM Inst Sci & Technol, SRM Coll Pharm, Dept Pharm Practice, Chennai 603203, Tamil Nadu, India
关键词
TUBERCULOSIS TREATMENT;
D O I
10.5588/ijtld.23.0054
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:778 / 780
页数:3
相关论文
共 50 条
  • [41] ROLE OF PATIENT CONTROL BELIEFS IN ADHERENCE TO A CHRONIC TREATMENT REGIMEN
    Howren, M. Bryant
    Christensen, Alan J.
    ANNALS OF BEHAVIORAL MEDICINE, 2013, 45 : S35 - S35
  • [42] Adherence to treatment regimen in depressed patients treated with amitriptyline or fluoxetine
    Demyttenaere, K
    Mesters, P
    Boulanger, B
    Dewe, W
    Delsemme, MH
    Gregoire, J
    Van Ganse, E
    JOURNAL OF AFFECTIVE DISORDERS, 2001, 65 (03) : 243 - 252
  • [43] Adherence to Antihyperglycemic Treatment Regimen Also Reduces Overall Costs
    Nguyen, Quang T.
    AMERICAN HEALTH AND DRUG BENEFITS, 2015, 8 (03): : 157 - 158
  • [44] Development & validation of hemophilia treatment regimen specific adherence scales
    Duncan, Natalie A.
    Shapiro, Amy D.
    Maahs, Jennifer A.
    Roberson, Christopher P.
    BLOOD, 2007, 110 (11) : 294A - 294A
  • [45] MEASURING ADHERENCE TO TREATMENT IN HIV USING A REGIMEN BASED APPROACH
    Swift, C.
    Mahler, J.
    Pegram, V
    Viteri, Y.
    Henderson, R.
    VALUE IN HEALTH, 2019, 22 : S210 - S210
  • [46] A single daily dose enhances the adherence to immunosuppressive treatment in kidney transplant recipients: a cross-sectional study
    Yoshitsugu Obi
    Naotsugu Ichimaru
    Taigo Kato
    Jun-ya Kaimori
    Masayoshi Okumi
    Koji Yazawa
    Hiromi Rakugi
    Norio Nonomura
    Yoshitaka Isaka
    Shiro Takahara
    Clinical and Experimental Nephrology, 2013, 17 : 310 - 315
  • [47] A single daily dose enhances the adherence to immunosuppressive treatment in kidney transplant recipients: a cross-sectional study
    Obi, Yoshitsugu
    Ichimaru, Naotsugu
    Kato, Taigo
    Kaimori, Jun-ya
    Okumi, Masayoshi
    Yazawa, Koji
    Rakugi, Hiromi
    Nonomura, Norio
    Isaka, Yoshitaka
    Takahara, Shiro
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2013, 17 (02) : 310 - 315
  • [48] Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen
    Mantefardo, Bahru
    Sisay, Gizaw
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2021, 14 : 815 - 817
  • [49] Dose-finding study of a once-daily indinavir/ritonavir regimen
    Hugen, PWH
    Burger, DM
    ter Hofstede, HJM
    Koopmans, PP
    Stek, M
    Hekster, YA
    Reiss, P
    Lange, JMA
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 25 (03) : 236 - 245
  • [50] The direct trial (daily-dose consensus interferon and ribavirin: efficacy of combined therapy): Treatment of non-responders to previous pegylated interferon plus ribavirin: Sustained virologic response data
    Bacon, Bruce
    Regev, Arie
    Ghalib, Reem H.
    Morelli, Giuseppe
    Rothstein, Kenneth D.
    Shiffman, Mitchell L.
    Hossanein, Tarek
    Hammond, Janet
    HEPATOLOGY, 2007, 46 (04) : 311A - 312A